FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
 OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                       
1. Name and Address of Reporting Person * Petersohn Walter 2. Issuer Name and Ticker or Trading Symbol DENTSPLY SIRONA Inc. [ XRAY ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Commercial Officer
(Last)         (First)         (Middle)
13320 BALLANTYNE CORPORATE PLACE		 3. Date of Earliest Transaction (MM/DD/YYYY)
11/17/2021
(Street)
CHARLOTTE, NC 28277
(City)       (State)       (Zip)
 4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
 6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)		 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)		 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)		 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  11/17/2021    S    34068  D $54.297 (1) 36487.1034  D   
Common Stock  11/17/2021    S    10747  D $54.0832 (2) 25740.1034  D   
Common Stock  11/17/2021    M    17748  A $47.41  43488.1034  D   
Common Stock  11/17/2021    S    17748  D $54.107 (3) 25740.1034  D   
Common Stock  11/17/2021    M    9300  A $40.12  35040.1034  D   
Common Stock  11/17/2021    S    9300  D $54.085 (4) 25740.1034  D   
Common Stock  11/17/2021    M    9134  A $49.29  34874.1034  D   
Common Stock  11/17/2021    S    9134  D $54.123 (5) 25740.1034  D   
Common Stock  11/17/2021    M    5434  A $47.84  31174.1034  D   
Common Stock  11/17/2021    S    5434  D $54.094 (6) 25740.1034  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)		 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)		 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)		 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)		 8. Price of Derivative Security
(Instr. 5)		 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  $47.41  11/17/2021    M        17748    (7) 11/25/2024  Common Stock  17748  $0  0  D   
Stock Option (Right to Buy)  $40.12  11/17/2021    M        9300    (8) 8/9/2028  Common Stock  9300  $0  0  D   
Stock Option (Right to Buy)  $49.29  11/17/2021    M        9134    (9) 3/12/2029  Common Stock  9134  $0  4566  D   
Stock Option (Right to Buy)  $47.84  11/17/2021    M        5434    (10) 3/4/2030  Common Stock  5434  $0  10866  D   

Explanation of Responses:
(1)  The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.19 to $54.43, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
(2)  The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.05 to $54.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
(3)  The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.06 to $54.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
(4)  The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
(5)  The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.00 to $54.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
(6)  The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.03 to $54.26, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
(7)  This option is fully vested and exercisable.
(8)  This option is fully vested and exercisable.
(9)  Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 12, 2022.
(10)  Stock Options vest in annual one-third (1/3) increments over a three-year period ending March 4, 2023.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Petersohn Walter
13320 BALLANTYNE CORPORATE PLACE
CHARLOTTE, NC 28277

Chief Commercial Officer

Signatures
/s/ Dane Baumgardner, Attorney-In-Fact for Walter Petersohn 11/19/2021
**Signature of Reporting Person Date
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more DENTSPLY SIRONA Charts.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more DENTSPLY SIRONA Charts.